Kneat Solutions is a SaaS startup based in Ireland that has been operating since 2005. The company's mission is encapsulated in its slogan, "Making validation easier, faster, and smarter for Life Sciences." Kneat Solutions specializes in digitizing validation processes for the Biopharma and Medical Device industries, offering a purpose-built software that streamlines and enhances the validation procedures. The platform, known as Kneat, complies with 21 CFR Part 11 and EudraLex Annex 11 standards, providing users with the ability to create, manage, access, and analyze validation data. Kneat eliminates the need for paper-based documentation, revolutionizing the entire validation, commissioning, and qualification processes. In January 23, 2024, Kneat Solutions received a significant $15.00M investment in Post-IPO Equity, indicating a strong investor interest in the company's vision and capabilities. Despite the absence of specific investor details, this substantial investment underscores the confidence in Kneat Solutions' potential to disrupt the life sciences validation landscape. As the life sciences industry continues to expand and undergo digital transformation, Kneat's innovative approach and proven compliance with industry regulations position it as a compelling investment opportunity. The company's ability to address critical pain points in validation processes with its cutting-edge SaaS solution presents a promising outlook for future growth and impact within the life sciences sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | $15.00M | - | 23 Jan 2024 | |
Post-IPO Equity | €14.90M | - | 04 May 2021 | |
Post-IPO Equity | $12.65M | - | 12 Mar 2020 | |
Post-IPO Equity | $11.00M | - | 27 Feb 2020 | |
Post-IPO Equity | $8.52M | - | 20 Feb 2019 |
No recent news or press coverage available for Kneat Solutions.